| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.00025 | 1 |